Código QR

Detection Rate and Clinical Impact of PET/CT with <sup>18</sup>F-FACBC in Patients with Biochemical Recurrence of Prostate Cancer: A Retrospective Bicentric Study

Our aim was to assess the detection rate (DR) of positron emission computed tomography (PET/CT) with anti-1-amino-3-[<sup>18</sup>F]-flurocyclobutane-1-carboxylic acid (<sup>18</sup>F-FACBC) in patients with biochemical recurrence (BCR) from prostate cancer (PC). As a secondary endpoint, we evaluate...

Descrición completa

Gardado en:
Principais autores: Luca Filippi, Oreste Bagni, Carmelo Crisafulli, Ivan Cerio, Gabriele Brunotti, Agostino Chiaravalloti, Orazio Schillaci, Franca Dore
Formato: Artigo
Idioma:Inglês
Publicado: MDPI AG 2022-01-01
Series:Biomedicines
Assuntos:
prostate cancer
PET/CT
<sup>18</sup>F-FACBC
<sup>18</sup>F-fluciclovine
biochemical recurrence
precision medicine
Acceso en liña:https://www.mdpi.com/2227-9059/10/1/177
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares